Search images on Google      Product Monograph

Active Ingredients:

• blinatumomab, 38.5 MCG/VIAL

DIN: 02450283

Dosage Form(s): POWDER FOR SOLUTION

Route(s) of Administration: INTRAVENOUS

Description: LYOPHILIZED POWDER. FOR I.V. INFUSION.

Schedule: Prescription

Company: AMGEN CANADA INC

ATC:

• L01 - ANTINEOPLASTIC AGENTS (ATC, WHO, Wiki)
• L01F - (ATC, WHO)
• L01FX - (ATC, WHO)
• L01FX07 - BLINATUMOMAB (WHO)

Packaging:

• Package size unit: No information
• Package type: No information
• Package size: No information
• Product information: 265ML TO 275ML (STARTING VOL)

 

External Links for Blincyto:

Search on Google

• Blincyto side effects
• Blincyto dosage
• blinatumomab side effects
• blinatumomab dosage